CDCA4 was shown to be upregulated in breast cancer (3), non-small cell lung cancer (4), osteosarcoma (5), head and neck squamous cell carcinoma (6), and ovarian cancer (6, 7). Here, CDCA4 is linked to ovarian carcinoma.